Click
HERE to view the virtual presentation for Oral-lyn treatment with IGT subjects given by Dr Andreea Soare from Italy's University Campus Bio Medico at the 48th EASD Annual Meeting on October 3rd, 2012 in Berlin, Germany. Currently, Oral-lyn is being reformulated by Generex to increase the potency to allow most patients to be treated with just two to four sprays at mealtimes (instead of 10 to 20 used in past trials). This is a very positive report, and obviously beneficial effect would be lost six months after treatment was discontinued.